Postdoctoral Scientist - Heart Institute - Rogers Lab
Cedars-Sinai Health System - Los Angeles, CA, United States
Posted Jun 5, 2025
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- Not verified
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Role
- Seniority
- Mid From the posting source
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Postdoctoral Scientist - Heart Institute - Rogers Lab Los Angeles, CA, United States The Smidt Heart Institute reflects Cedars-Sinai's steadfast dedication to heart disease and research innovation giving patients access to the highest level of care. Year after year, thousands of people trust their hearts to Smidt Heart Institute at Cedars-Sinai. Our cardiologists, cardiac surgeons and niche care teams treat the full spectrum of heart disease and disorders, while our investigators continue to advance the field with groundbreaking, life-saving research. From genetic counseling and targeted drug therapies to a growing array of minimally invasive procedures, Cedars-Sinai continues to stand at the forefront of technology, innovation and discovery improving patient outcomes. Are you ready to be a part of breakthrough research? The Rogers Laboratory focuses on cell therapy and regenerative medicine. Research conducted in the Rogers Lab stems largely from the pioneering work of Eduardo Marbán, MD, PhD, who mentored Dr. Rogers as a postdoctoral scholar. The Marbán Lab was first to isolate and characterize cardiosphere-derived cells (CDCs), a type of heart progenitor/stromal cell now in advanced clinical trials. Initial studies documented the reparative benefits of CDCs when delivered directly into dystrophic hearts. Subsequent research showed CDCs to be effective in dystrophic hearts and skeletal muscle when delivered intravenously - a clinically preferable method. This work motivated a Phase II (HOPE-2) and Phase III (HOPE-3) clinical trial to repeatedly deliver allogeneic CDCs intravenously to human patients with advanced-stage Duchenne muscular dystrophy. To learn more, please visit Rogers Lab at Cedars-Sinai .
Read the full description at hdkk.fa.us6.oraclecloud.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Postdoctoral Scientist - Heart Institute
Cedars-Sinai Health System - Los Angeles, CA, United States
Associate Scientist III, Cardiac Modeling
Insitro - South San Francisco, CA
Principal Scientist, Translational Biology
Cytokinetics Inc - South San Francisco, California
Cardiac Ultrasound Technician (Associate Scientist/ Scientist)
Edgewise Therapeutics Inc - Boulder, CO